首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of headache and pain

缩写:J HEADACHE PAIN

ISSN:1129-2369

e-ISSN:1129-2377

IF/分区:7.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2404
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ying Huang,Wen Yan,Yifan Jia et al. Ying Huang et al.
Background: Migraine has been linked to a heightened risk of cardiovascular disease, and acute treatment drugs, such as triptans, might increase this risk. This study aimed to determine whether the elevated cardiovascular...
Seung Ae Kim,Eung Yeop Kim,Shuu-Jiun Wang et al. Seung Ae Kim et al.
Background: The diagnosis of reversible cerebral vasoconstriction syndrome (RCVS) is challenging due to its varied clinical manifestations and imaging findings. While it typically presents with a sudden, severe thundercla...
Marcin Straburzyński,Daria Kopyt,Karol Marschollek et al. Marcin Straburzyński et al.
Background: Calcitonin gene related peptide (CGRP) pathway targeting therapies have proven efficacy, safety and tolerability. However, CGRP is also involved in immune responses, and reports of an increased risk of infecti...
William K Karlsson,Rune H Christensen,Haidar M Al-Khazali et al. William K Karlsson et al.
Background: Soluble urokinase-plasminogen activator receptor (suPAR) is a biomarker of systemic inflammation and elevated in plasma of individuals with migraine with aura. As inflammatory cytokines can upregulate calciton...
Flavia Brugia,Konstantin Ivanov,Auni Aroviita et al. Flavia Brugia et al.
Background: Migraine is a common neurovascular disorder that remains currently untreated in half of the patients. One third of migraine patients experience aura, which is associated with the development of cortical spread...
Elizaveta Mangutov,Yaseen Awad-Igbaria,Kendra Siegersma et al. Elizaveta Mangutov et al.
Background: Migraine affects over 1 billion people worldwide and is a leading cause of disability. Targeting the cannabinoid system offers a promising approach for pain and migraine relief. This study evaluated a novel mo...
Lanfranco Pellesi,Thien Phu Do,Martin Thomsen Ernst et al. Lanfranco Pellesi et al.
Background: Rimegepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, is the first drug within its class approved for both acute and preventive treatment of migraine. This study examines its uptake i...
Giorgia Elisabeth Colombo,Sofia Makieva,Edgardo Somigliana et al. Giorgia Elisabeth Colombo et al.
Background: Endometriosis affects women of reproductive age. Increasing attention is being given to the characterization of comorbidities in endometriosis to enhance clinical phenotyping. Among these comorbidities, migrai...